erofeyporgrinin.blogspot.com
Baldino had been on the ViroPharmaa (NASDAQ:VPHM) board from 1996 to 2006. ViroPharma is an Exton, Pa.-basedf biopharmaceutical company. Last week it announced that the wantxs an additional clinical study on its experimental hereditaryangiodema (HAE) drug Cinryze before the agencu will render a decision. HAE is a life-threatening, condition that causes swellingg in various body parts includingthe feet, face and throat. The drug is alreadyg approved for use in preventingHAE attacks.
ViroPharma’s othere approved drug is Vancocin, an antibioticf used to treat bacterial infections of the lower digestivse tract that result in a potentially fatal condition knownm asclostridium difficile-associated disease. Cephalon is an international company that focusese on developing drugs in four core therapeutic centralnervous system, pain, oncology and Baldino sits on several other including the trustees at Temple University, the Franklimn science museum and the Greater Philadelphia Chamber of Commerce.
No comments:
Post a Comment